Stockscreener 앱 받기
0.00
100.00%
-21.64
전일 마감가:
$21.64
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$2.12B
수익:
$248.52M
순이익/손실:
$-278.00K
주가수익비율:
0.00
EPS:
-0.0055
순현금흐름:
$36.80M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
명칭
Avadel Pharmaceuticals Plc
전화
636-449-1830
주소
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
0.00 | 2.12B | 248.52M | -278.00K | 36.80M | -0.0055 |
TAK
Takeda Pharmaceutical Co Adr
|
18.66 | 58.95B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
119.75 | 50.55B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.97 | 44.44B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.52 | 35.54B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
581.69 | 25.49B | 3.18B | 1.33B | 1.04B | 27.90 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | 개시 | Wells Fargo | Equal Weight |
| 2025-07-18 | 재개 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-06-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-03-05 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-05 | 재확인 | Needham | Buy |
| 2024-03-05 | 재확인 | Oppenheimer | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2022-11-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-28 | 재개 | Craig Hallum | Buy |
| 2022-05-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-23 | 개시 | Needham | Buy |
| 2020-07-31 | 개시 | Oppenheimer | Outperform |
| 2020-07-21 | 개시 | SVB Leerink | Outperform |
| 2020-06-30 | 개시 | H.C. Wainwright | Buy |
| 2020-04-03 | 개시 | Jefferies | Buy |
| 2020-03-12 | 개시 | Stifel | Buy |
| 2020-02-26 | 개시 | Piper Sandler | Overweight |
| 2020-01-30 | 개시 | Craig Hallum | Buy |
| 2019-06-14 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
모두보기
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
Jefferies Downgrades Avadel Pharmaceuticals (AVDL) - MSN
Wells Fargo Initiates Coverage of Avadel Pharmaceuticals (AVDL) with Equal-Weight Recommendation - MSN
Risk Check: What is the dividend yield of Avadel Pharmaceuticals plc2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Patterns: What is the earnings history of Avadel Pharmaceuticals plc2026 Momentum Check & Capital Protection Trade Alerts - baoquankhu1.vn
Leerink Partners Downgrades Avadel Pharmaceuticals (AVDL) - MSN
Update Recap: What are the future prospects of Avadel Pharmaceuticals plc - baoquankhu1.vn
EBITDA per share of Avadel Pharmaceuticals plc – LS:A2DJ5B - TradingView
Free cash flow per share of Avadel Pharmaceuticals plc – LS:A2DJ5B - TradingView
Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War - MSN
Avadel Pharmaceuticals plc Financial Disclosures & Filings - TradingView
Avadel Pharmaceuticals Shares Climb on $2.1 Billion Acquisition by Alkermes - MSN
AVDL Avadel Pharmaceuticals (NASDAQ) $21.64 05 Mar 2026: earnings set to guide next move - Meyka
Pullback Watch: Should I hold or sell Avadel Pharmaceuticals plc now2025 Market Trends & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Avadel Merger Finalized as Market Focus Shifts to Clinical Pipeline - AD HOC NEWS
Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the Healthcare Sector with a Promising 54.9% Revenue Growth - DirectorsTalk Interviews
Quarterly Risk: Is Avadel Pharmaceuticals plc a good stock for dollar cost averaging2025 AllTime Highs & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Avadel Pharmaceuticals (AVDL) to Release Earnings on Monday - Defense World
[15-12G] AVADEL PHARMACEUTICALS PLC SEC Filing - Stock Titan
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Cross Above 200-Day Moving Average – What’s Next? - Defense World
Is Avadel Pharmaceuticals plc vulnerable to short sellers2025 Top Gainers & Short-Term Trading Opportunity Alerts - mfd.ru
Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating a 54.9% Revenue Growth Amidst Analyst Caution - DirectorsTalk Interviews
Best Pharmaceutical Stocks To Follow Now – February 17th - Defense World
Weiss Asset funds cash out 11.1M Avadel (AVDL) shares in Alkermes deal - Stock Titan
Mid Cap Stocks To Follow NowFebruary 18th - MarketBeat
Best Pharmaceutical Stocks To Watch TodayFebruary 18th - MarketBeat
Avadel (AVDL) stock: new SEC filing as shares stay suspended after $21 Alkermes buyout - Bez Kabli
Two Seas Capital reports 0% ownership in Avadel Pharmaceuticals (AVDL) - Stock Titan
Top Mid Cap Stocks To ConsiderFebruary 17th - MarketBeat
Best Pharmaceutical Stocks To Follow NowFebruary 17th - MarketBeat
[EFFECT] AVADEL PHARMACEUTICALS PLC SEC Filing - Stock Titan
Ireland's Alkermes plc buys Avadel Pharmaceuticals plc - ALCHEMPro
3 European Stocks Estimated To Be Trading Up To 48.2% Below Intrinsic Value - simplywall.st
Avadel Pharmaceuticals plc acquired by Alkermes plc - Arthur Cox LLP
FOMO Trade: Is Avadel Pharmaceuticals plc vulnerable to short sellersJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Alkermes Completes $2.1 Billion Acquisition of Avadel Pharmaceuticals - CHEManager
Best Pharmaceutical Stocks To Follow TodayFebruary 13th - MarketBeat
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Short Interest Down 36.0% in January - MarketBeat
Alkermes plc completes acquisition of Avadel Pharmaceuticals plc, accelerating entry into sleep medicine market - marketscreener.com
Pharmaceutical Stocks To Watch TodayFebruary 12th - MarketBeat
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - BioSpace
Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market - TradingView
Alkermes PLC has successfully completed the acquisition of Avadel Pharmaceuticals plc. - Bitget
Alkermes Acquires Avadel Pharmaceuticals - Contract Pharma
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Alkermes Completes Acquisition and Delisting of Avadel Pharmaceuticals - TipRanks
Avadel Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Alkermes (Nasdaq: ALKS) closes Avadel acquisition, adds LUMRYZ and $1.5B loans - Stock Titan
RFG Advisory LLC Acquires New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Alkermes Completes Acquisition of Avadel Pharmaceuticals, Adding LUMRYZ to Portfolio - Sleep Review
(AVDL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Growth Recap: Is Avadel Pharmaceuticals plc stock a falling knife or bargain buyQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Avadel Pharmaceuticals Plc (AVDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.24%
자본화:
|
볼륨(24시간):